{
    "Trade/Device Name(s)": [
        "ALFIS Vitamin D",
        "ALFIS-3 Analyzer"
    ],
    "Submitter Information": "Immunostics Inc.",
    "510(k) Number": "K221817",
    "Predicate Device Reference 510(k) Number(s)": [
        "K210901"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MRG",
        "KHO"
    ],
    "Summary Letter Date": "March 24, 2023",
    "Summary Letter Received Date": "March 27, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1825"
    ],
    "Regulation Name(s)": [
        "Vitamin D Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Total 25-hydroxy Vitamin D",
        "25-OH Vitamin D"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparin plasma",
        "Sodium heparin plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ALFIS-3 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked fluorescence immunoassay"
    ],
    "Methodologies": [
        "Fluorescence scanning",
        "Magnetic bead-based assay",
        "Alkaline phosphatase enzyme system"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Calibrator",
        "Control",
        "Cartridge",
        "ID Chip"
    ],
    "Document Summary": "FDA 510(k) summary for ALFIS Vitamin D enzyme-linked fluorescence immunoassay and ALFIS-3 Analyzer for quantitative measurement of total 25-hydroxy vitamin D in human serum and plasma",
    "Indications for Use Summary": "For quantitative measurement of total 25-hydroxy Vitamin D in human serum and heparin plasma to aid in determination of Vitamin D sufficiency in adults, used at clinical laboratories",
    "fda_folder": "Clinical Chemistry"
}